The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
908 DEVICES INC COM 65443P102 6,205 326,427 SH   SOLE   326,427 0 0
ABSCI CORP. COM 00091E109 487 57,804 SH   SOLE   57,804 0 0
ACUMEN PHARMACEUTICALS, INC COM 00509G209 13,361 3,417,075 SH   SOLE   3,417,075 0 0
CANDEL THERAPEUTICS, INC COM 137404109 4,132 811,737 SH   SOLE   811,737 0 0
CINCOR PHARMA, INC. COM 17240Y109 16,663 950,000 SH   SOLE   950,000 0 0
DICE THERAPEUTICS, INC. COM 23345J104 60,240 3,148,970 SH   SOLE   3,148,970 0 0
KARUNA THERAPEUTICS, INC. COM 48576A100 33,966 267,895 SH   SOLE   267,895 0 0
OLINK HOLDING AB COM 680710100 7,515 425,514 SH   SOLE   425,514 0 0
REPLIGEN CORP. COM 759916109 4,240 22,544 SH   SOLE   22,544 0 0
SPRUCE BIOSCIENCES INC COM 85209E109 1,582 787,007 SH   SOLE   787,007 0 0
TARSUS PHARMACEUTICALS INC COM 87650L103 4,373 260,000 SH   SOLE   260,000 0 0
TAYSHA GENE THERAPIES INC COM 877619106 4,726 724,873 SH   SOLE   724,873 0 0
DOORDASH INC COM CL A 25809K105 70,484 601,454 SH   SOLE   601,454 0 0
NU HOLDINGS LTD. COM CL A G6683N103 70,536 9,136,835 SH   SOLE   9,136,835 0 0
SAMSARA, INC. COM CL A 79589L106 5,223 326,000 SH   SOLE   326,000 0 0
SAMSARA, INC. COM CL B FDS1Q2O30 43,450 2,712,256 SH   SOLE   27,122,560 0 0
SNOWFLAKE INC COM CL A 833445109 49,176 214,621 SH   SOLE   214,621 0 0
UIPATH INC COM CL A 90364P105 82,296 3,811,779 SH   SOLE   3,811,779 0 0